SCHEMBL9099739

SCHEMBL9099739

Nc1ccc2ccc(C=O)cc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
CYP3A4 P08684 3/20 0.48
HSD17B10 Q99714 2/20 0.48
TDP1 Q9NUW8 2/20 0.46
ALOX15 P16050 1/20 0.46
CASP1 P29466 1/20 0.46
CASP7 P55210 1/20 0.46
HBB P68871 1/20 0.46
HIF1A Q16665 1/20 0.46
CYP2A6 P11509 6/20 0.42
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 1/20 0.40
PTGS2 P35354 1/20 0.40
RAB9A P51151 1/20 0.40
PLAU P00749 1/20 0.38
TRIM24 O15164 1/20 0.37
HPGD P15428 1/20 0.37
ALDH5A1 P51649 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29954379 1.00 ALDH1A1 (0.48) ALDH1A1CYP3A4HSD17B10TDP1ALOX15
SCHEMBL5750176 0.94 ALDH1A1 (0.56) ALDH1A1CYP3A4HSD17B10TDP1ALOX15
SCHEMBL5748061 0.94 ALDH1A1 (0.56) ALDH1A1CYP3A4HSD17B10TDP1ALOX15
SCHEMBL2346924 0.93 ALDH1A1 (0.50) ALDH1A1CYP3A4HSD17B10TDP1ALOX15
SCHEMBL29957342 0.93 ALDH1A1 (0.50) ALDH1A1CYP3A4HSD17B10TDP1ALOX15
SCHEMBL1487663 0.86 CYP2A6 (0.52) ALDH1A1HSD17B10TDP1CYP2A6KDM4E
SCHEMBL29433921 0.86 CYP2A6 (0.52) ALDH1A1HSD17B10TDP1CYP2A6KDM4E
SCHEMBL19182196 0.79 CYP2A6 (0.50) ALDH1A1HSD17B10TDP1CYP2A6KDM4E
SCHEMBL9883838 0.79 CYP2A6 (0.50) ALDH1A1HSD17B10TDP1CYP2A6KDM4E
SCHEMBL30972495 0.79 CYP2A6 (0.50) ALDH1A1HSD17B10TDP1CYP2A6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0323441-B1 5-Fluorouracil derivatives OTSUKA PHARMA CO LTD (JP) 1996-04-24 EP disclosed
EP-0436902-B1 5-Fluorouracil derivatives OTSUKA PHARMA CO LTD (JP) 1995-06-28 EP disclosed
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 US disclosed
EP-0180188-B1 A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 EP disclosed
EP-0180897-B1 5-FLUOROURACIL DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-08-07 EP disclosed
EP-0436902-A1 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-07-17 EP disclosed
US-4983609-A Anticancer agents OTSUKA PHARMACEUTICAL (JP) 1991-01-08 US disclosed
US-4864021-A ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-09-05 US disclosed
EP-0323441-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-07-05 EP disclosed
EP-0180897-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-14 EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed